Cargando…

Cytomegalovirus retinitis in children post hematopoietic stem cell transplantation: Can we develop a screening protocol?

Detalles Bibliográficos
Autores principales:	Al-Farsi, Nouf, Al Jabri, Samira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979378/ https://www.ncbi.nlm.nih.gov/pubmed/35388243 http://dx.doi.org/10.4103/ojo.ojo_28_22

Ejemplares similares

Incontinentia pigmenti: What we know and can we manage it as retinopathy of prematurity?
por: Al-Farsi, Nouf, et al.
Publicado: (2022)

Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation
por: Kim, Joo Young, et al.
Publicado: (2020)

Can we treat retinopathy of prematurity under topical anesthesia?
por: Al-Farsi, Nouf, et al.
Publicado: (2021)

Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation
por: Wang, Xiaona, et al.
Publicado: (2023)

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
por: Dieamant, Débora C, et al.
Publicado: (2013)

Pre-Transplant Platelet Refractoriness and Alternative Donors Are Associated With Cytomegalovirus Retinitis in Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia
por: Zhang, Yuehong, et al.
Publicado: (2022)

Total Body Irradiation for Hematopoietic Stem Cell Transplantation: What Can We Agree on?
por: Sabloff, Mitchell, et al.
Publicado: (2021)

Late cytomegalovirus infection after hematopoietic stem cell transplantation: case reports
por: Pinheiro, Sâmara Grapiuna, et al.
Publicado: (2013)

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
por: Ong, Shin-Yeu, et al.
Publicado: (2015)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Stern, Lauren, et al.
Publicado: (2019)

The Perceived Threat in Adults with Leukemia Undergoing Hematopoietic Stem Cell Transplantation
por: Farsi, Zahra, et al.
Publicado: (2013)

926. Risk factors for post-letermovir cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell transplant (HSCT) recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

Antiviral therapy defiant mixed viral retinitis post hematopoietic allogeneic stem cell transplant
por: Gabarin, Nadia, et al.
Publicado: (2023)

Standardized monitoring of cytomegalovirusspecific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation
por: Wagner-Drouet, Eva, et al.
Publicado: (2019)

Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation
por: Jaing, Tang-Her, et al.
Publicado: (2019)

Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy
por: Cho, Sung-Yeon, et al.
Publicado: (2019)

Cytomegalovirus disease in patients with hematopoietic stem cell transplantation, experience over 8 years
por: Diaz, Laura, et al.
Publicado: (2020)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
por: Mardani, Masoud, et al.
Publicado: (2020)

Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation
por: Cui, Jiaqi, et al.
Publicado: (2022)

The Ten Most Common Questions on Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Patients
por: Zakhour, Johnny, et al.
Publicado: (2022)

2487. Vaccination Rates in Post-Transplant Hematopoietic Stem Cell Transplant (HSCT) Patients: Where Do We Stand?
por: Ahmad, Hiba, et al.
Publicado: (2018)

Peripheral blood lymphocyte responses to cytomegalovirus seropositivity after allogeneic-hematopoietic stem cell transplantation
por: Zhang, Jiexin, et al.
Publicado: (2018)

Incidence and Outcomes of Cytomegalovirus (CMV) Infection among Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Furuno, Jon P, et al.
Publicado: (2017)

Profiling the Blood Compartment of Hematopoietic Stem Cell Transplant Patients During Human Cytomegalovirus Reactivation
por: Bernshtein, Biana, et al.
Publicado: (2021)

Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation
por: Zhou, Xinyi, et al.
Publicado: (2021)

Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation
por: Li, Shan-shan, et al.
Publicado: (2022)

Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation
por: Sato, Kazuya, et al.
Publicado: (2022)

Impact of cytomegalovirus infection prior to hematopoietic stem cell transplantation in children with inborn errors of immunity
por: del Rosal, Teresa, et al.
Publicado: (2022)

Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation
por: Xia, Jintao, et al.
Publicado: (2022)

P1617: CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS DRUG RESISTANCE GENE MUTATIONS IN CYTOMEGALOVIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: yang, D., et al.
Publicado: (2022)

Letermovir for Cytomegalovirus Prevention in Patients Undergoing Hematopoietic Cell Transplantation
por: Daniels, Kori, et al.
Publicado: (2019)

Clofarabine in Pediatric Acute Relapsed or Refractory Leukemia: Where Do We Stand on the Bridge to Hematopoietic Stem Cell Transplantation?
por: Ramiz, Sarah, et al.
Publicado: (2023)

Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation
por: da Rocha, Luis Klaus A., et al.
Publicado: (2018)

Can the bone marrow harvest volume be reduced safely in hematopoietic stem cell transplantation with pediatric sibling donors?
por: AlAnazi, Awatif, et al.
Publicado: (2023)

Quantification of Cytomegalovirus Glycoprotein Bn DNA in Hematopoietic Stem Cell Transplant Recipients by Real-time PCR
por: Zhang, Xuan, et al.
Publicado: (2012)

Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy
por: Kim, Tark, et al.
Publicado: (2016)

Single-cell profiling reveals the dynamics of cytomegalovirus-specific T cells in haploidentical hematopoietic stem cell transplantation
por: van Beek, Jasper J. P., et al.
Publicado: (2021)

NEOVASCULAR COMPLICATIONS FROM CYTOMEGALOVIRUS NECROTIZING RETINOPATHY IN PATIENTS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Long, Ze, et al.
Publicado: (2021)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
por: Restelli, Umberto, et al.
Publicado: (2019)

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
por: Prockop, Susan E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jogsb1c4hqiidgluagbg02i5fi